Is The SPDR ASX 50 ETF (SFY) Better Than A200?
Max Wagner
September 20, 2019
There are several ASX ETFs designed to track the S&P/ASX
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
There are several ASX ETFs designed to track the S&P/ASX
The iShares Edge MSCI Australia Multifactor ETF (ASX: AUMF) is
I think CSL Limited (ASX:CSL) shares would be up there
The CSL Limited (ASX:CSL) share price rose by almost 7%
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
The ASX 200 (INDEXASX:XJO)(^AXJO) is expected to open higher today,
The CSL Limited (ASX:CSL) share price could be one of
CSL Limited (ASX:CSL) is Australia’s largest (and some might say
A decade after the last high, the ASX 200 (INDEXASX:XJO)(^AXJO)
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
